Retail Healthcare Sector

CareDx

Market Cap: US$892.0m

Engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally.

Spyre Therapeutics

Market Cap: US$890.2m

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

Syndax Pharmaceuticals

Market Cap: US$876.8m

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Pharvaris

Market Cap: US$875.7m

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Avadel Pharmaceuticals

Market Cap: US$873.6m

Operates as a biopharmaceutical company in the United States.

Extendicare

Market Cap: CA$1.2b

Through its subsidiaries, provides care and services for seniors in Canada.

HealthStream

Market Cap: US$836.7m

Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.

AMN Healthcare Services

Market Cap: US$829.6m

Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.

Intellia Therapeutics

Market Cap: US$816.2m

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

LENZ Therapeutics

Market Cap: US$815.1m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

Ardelyx

Market Cap: US$811.1m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

SI-BONE

Market Cap: US$792.2m

A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

CorMedix

Market Cap: US$788.8m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Xeris Biopharma Holdings

Market Cap: US$784.8m

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

Zymeworks

Market Cap: US$783.9m

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

Cronos Group

Market Cap: CA$1.1b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Niagen Bioscience

Market Cap: US$768.1m

Operates as a bioscience company engages in developing healthy aging products.

CureVac

Market Cap: US$764.4m

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Geron

Market Cap: US$764.3m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

WELL Health Technologies

Market Cap: CA$1.1b

Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.

Praxis Precision Medicines

Market Cap: US$755.7m

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

Nuvation Bio

Market Cap: US$745.2m

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

Embecta

Market Cap: US$730.5m

A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.

Nurix Therapeutics

Market Cap: US$730.3m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Nika Pharmaceuticals

Market Cap: US$728.7m

Engages in the development and distribution of various pharmaceutical products.

Rocket Pharmaceuticals

Market Cap: US$712.7m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Veradigm

Market Cap: US$712.6m

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.

Bicara Therapeutics

Market Cap: US$711.2m

A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.

uniQure

Market Cap: US$701.1m

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

Nutex Health

Market Cap: US$696.2m

Operates as a physician-led, healthcare services, and operations company in the United States.

Immunome

Market Cap: US$693.5m

A clinical-stage biotechnology company, develops targeted cancer therapies.

Anavex Life Sciences

Market Cap: US$693.2m

A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

Mesa Laboratories

Market Cap: US$689.7m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

IRADIMED

Market Cap: US$660.0m

Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.

PolyNovo

Market Cap: AU$1.0b

Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.

Trevi Therapeutics

Market Cap: US$656.8m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough conditions targeting the central and peripheral nervous systems.